There is accumulating evidence that the chronic-low grade inflammation associated with obesity plays an important role in the development of metabolic disease. Although a number of molecular pathways connecting inflammation and metabolism have been discovered, numerous gaps remain in our understanding of how inflammatory signals disrupt normal glucose and lipid homeostasis, particularly concerning the role of different cytokines. This is especially true of the classic inflammatory cytokine, Il-6. Although elevated Il-6 levels are a risk factor for the development of metabolic disease, numerous beneficial effects of the cytokine on glucose metabolism have been observed. Il-6 appears to be is a key player in a subcutaneous adipose tissue:hepatic axis, whereby Il-6 secreted from subcutaneous adipose tissue suppresses hepatic gluconeogenesis via the phosphorylation and activation of Stat3. The noncanonical I?B kinases Ikk-? and Tbk1, which are induced downstream of the inflammatory mediator NF-?B, suppress this axis in the obese state. Inhibition of Ikk-?/Tbk1 by the drug amlexanox restores the balance of this axis, providing an ideal system for investigating the in vivo effects of Il-6 signaling in the context of obesity. Using this established system, Il-6 signaling and its effects on metabolic disease will be examined.
The first aim will focus on the hepatic effects of Il-6 and their dependence on hepatic Stat3 activation.
The second aim will investigate the extra hepatic effects of Il-6 signaling on glucose metabolism, looking into the regulation of glucose handling in peripheral tissues and the specific role of Glp-1 in the pancreas.
The third aim will focus on Il-6 signaling within the adipoe tissue, from adipocytes to immune cells. The applicant's long-term career goal is to make a significant contribution to the understanding of the pathology of obesity and the development of metabolic disease. This career development award will enable the applicant to develop the skills required to become an independent investigator, leading a basic research laboratory at an academic institution in a tenure track faculty position, where the applicant will have the best chance of achieving her long-term goal. These skills will be developed at the University of Michigan, an excellent environment in which to perform health sciences related research, with many available resources including career development workshops. The Life Sciences Institute provides a fantastic collaborative environment in which to perform basic research with translational potential. Collaborations between faculty and physicians provide opportunities for the translation of basic research into the clinical setting. The applicant will utilize the resourcs available at the University of Michigan, as well as guidance and support of the Mentoring and Advisory Committees, to complete the proposed research, and develop as an independent investigator.

Public Health Relevance

World-wide obesity rates pose a significant threat to public health. I propose to investigate the role of the cytokine Il-6 in the reversal of obesity-associate metabolic diseases. This research will contribute to the basic understanding of tissue crosstalk in metabolic diseases and hopefully lead to new therapeutic approaches to treat or prevent these devastating disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
1K01DK105075-01A1
Application #
9032178
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
2015-09-16
Project End
2018-07-31
Budget Start
2015-09-16
Budget End
2016-07-31
Support Year
1
Fiscal Year
2015
Total Cost
$163,608
Indirect Cost
$12,119
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Ahmadian, Maryam; Liu, Sihao; Reilly, Shannon M et al. (2018) ERR? Preserves Brown Fat Innate Thermogenic Activity. Cell Rep 22:2849-2859
Beyett, Tyler S; Gan, Xinmin; Reilly, Shannon M et al. (2018) Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKK? for the treatment of obesity. Bioorg Med Chem 26:5443-5461
Beyett, Tyler S; Gan, Xinmin; Reilly, Shannon M et al. (2018) Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK? and Reveal Mechanisms for Selective Inhibition. Mol Pharmacol 94:1210-1219
Oral, Elif A; Reilly, Shannon M; Gomez, Andrew V et al. (2017) Inhibition of IKK? and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes. Cell Metab 26:157-170.e7
Reilly, Shannon M; Saltiel, Alan R (2017) Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol 13:633-643